OGN beat EPS expectations by 12.43%
May 02, 2025, 10:36 AM
0.00%
What does OGN do
Organon & Co., headquartered in Jersey City, develops innovative health solutions in women’s health, biosimilars, and established brands, employing 10,000 people and operating six manufacturing facilities worldwide. The company went public on May 14, 2021, and offers products like Nexplanon and Follistim AQ through various distribution channels.
Organon & Company (OGN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Organon & Company's actual EPS was $1.02, beating the estimate of $0.91 per share, resulting in a 12.43% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.